Lacidipine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
3,5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
CAS number | 103890-78-4 |
ATC code | C08CA09 |
PubChem | CID 5311217 |
UNII | 260080034N |
KEGG | D04657 |
Chemical data | |
Formula | C26H33NO6 |
Mol. mass | 455.543 g/mol |
(what is this?) (verify) | |
Lacidipine (tradenames Lacipil (GSK) or Motens (Boehringer Ingelheim)) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
External links
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.